University of Iowa researchers have discovered a gene that plays a linchpin role in the ability of breast cancer cells to respond to estrogen. The finding may lead to improved therapies for hormone-responsive breast cancers and may explain differences in the effectiveness of current treatments.
Estrogen causes hormone-responsive breast cancer cells to grow and divide by interacting with estrogen receptors made by cancer cells. Interfering with estrogen signaling is the basis of two common breast cancer therapies -- tamoxifen, which blocks estrogen's interaction with a primary estrogen receptor called ER-alpha, and aromatase inhibitors that reduce the amount of estrogen the body makes and therefore affect any pathway that uses estrogen.
The study, led by Ronald Weigel, M.D., Ph.D., professor and head of surgery at the University of Iowa Roy J. and Lucille A. Carver College of Medicine, reveals a central role for transcription factor AP2C (TFAP2C) in controlling multiple pathways of estrogen signaling. The findings are published in the Sept. 15 issue of Cancer Research.
"Estrogen binds to estrogen receptors and triggers a cascade of events including gene regulation," said Weigel, who also is a member of the Holden Comprehensive Cancer Center at the UI. "We found that elimination of the TFAP2C from the cell causes all of those cascades that we associate with estrogen to go away. The treated cancer cells were not able to respond to estrogen by any normal pathway."
The researchers found that silencing expression of TFAP2C in hormone-responsive breast cancer cells significantly decreased the amount of ER-alpha made by the cancer cell. This reduction in ER-alpha (down to 16 percent of the level normally made by breast cancer cells) also affected production of other "downstream" genes involved in cancer growth.
In addition, silencing the TFAP2C also knocked out expression of another estrogen receptor called GPR30 that is
'/>"/>
| Contact: Jennifer Brown jennifer-l-brown@uiowa.edu 319-335-9917 University of Iowa Source:Eurekalert |
Related biology news :
1. UCSD discovery may provide novel method to generate medically useful proteins
2. Scientists fetch useful information from dog genome publications
3. One-of-a-kind imaging probe reveals secrets useful for drug discovery
4. Scientists seek useful traits in wild cottons
5. Dual-imaging technique useful before -- and during -- brain surgery
6. New binding target for oncogenic viral protein
7. Ancient olfaction protein is shared by many bugs, offering new pest control target
8. Novel Enzyme Shows Potential As An Anti-HIV Target
9. A bacterial genome reveals new targets to combat infectious disease
10. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
11. Researchers identify target for cancer drugs
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |